scholarly journals Effects of Food Components on Intestinal Flora, Intestinal Immune System and their Mutualism

2010 ◽  
Vol 29 (2) ◽  
pp. 69-82 ◽  
Author(s):  
Shuichi Kaminogawa
2005 ◽  
Vol 64 (4) ◽  
pp. 451-457 ◽  
Author(s):  
M. Bailey ◽  
K. Haverson ◽  
C. Inman ◽  
C. Harris ◽  
P. Jones ◽  
...  

The mucosal immune system fulfils the primary function of defence against potential pathogens that may enter across vulnerable surface epithelia. However, a secondary function of the intestinal immune system is to discriminate between pathogen-associated and ‘harmless’ antigens, expressing active responses against the former and tolerance to the latter. Control of immune responses appears to be an active process, involving local generation of IgA and of regulatory and/or regulated T lymphocytes. Two important periods of maximum exposure to novel antigens occur in the young animal, immediately after birth and at weaning. In both cases the antigenic composition of the intestinal contents can shift suddenly, as a result of a novel diet and of colonisation by novel strains and species of bacteria. Changes in lifestyles of man, and husbandry of animals, have resulted in weaning becoming much more abrupt than previously in evolution, increasing the number of antigens that must be simultaneously evaluated by neonates. Thus, birth and weaning are likely to represent hazard and critical control points in the development of appropriate responses to pathogens and harmless dietary and commensal antigens. Neonates are born with relatively undeveloped mucosal immune systems. At birth this factor may prevent both expression of active immune responses and development of tolerance. However, colonisation by intestinal flora expands the mucosal immune system in antigen-specific and non-specific ways. At weaning antibody to fed proteins can be detected, indicating active immune responses to fed proteins. It is proposed that under normal conditions the ability of the mucosal immune system to mount active responses to foreign antigens develops simultaneously with the ability to control and regulate such responses. Problems arise when one or other arm of the immune system develops inappropriately, resulting in inappropriate effector responses to harmless food proteins (allergy) or inadequate responses to pathogens (disease susceptibility).


2016 ◽  
Vol 23 (3) ◽  
pp. 413-426 ◽  
Author(s):  
Daniel A. Winer ◽  
Helen Luck ◽  
Sue Tsai ◽  
Shawn Winer

2000 ◽  
Vol 59 (2) ◽  
pp. 215-220 ◽  
Author(s):  
Fiona Armstrong ◽  
J. C. Mathers

At its most fundamental, cancer is a genetic disease resulting from inherited or acquired mutations in tumour suppressor genes and proto-oncogenes. Environmental factors, including ingested food components, interact with genetic inheritance to determine individual cancer risk. There is growing evidence that the immune system exerts selective pressure during neoplastic development. Tumour cells that evade this immunosurveillance because they are non-antigenic or because they defend themselves successfully against immune attack have a survival advantage. Effective chemopreventative agents will include dietary components that enhance the immune system’s ability to identify transformed cells and to target them for apoptosis.


Author(s):  
Aline Gamarra Taborda FLESCH ◽  
Aline Kirjner POZIOMYCK ◽  
Daniel De Carvalho DAMIN

INTRODUCTION: Functional foods are health promoters and their use is associated with reduced risk of chronic degenerative and non-transmissible diseases. Examples are symbiotic. The association of one (or more) probiotic with a one (or more) prebiotic is called symbiotic, being the prebiotics complementary and probiotics synergistic, thus presenting a multiplicative factor on their individual actions. OBJECTIVE: To assess the evidences on the benefits of the use of symbiotics in the treatment of clinical and surgical situations. METHODS: The headings symbiotic, probiotic and prebiotic were searched in Pubmed/Medline in the last 15 years, and were selected 25 articles, used for database. RESULTS: The use of symbiotic may promote an increase in the number of bifidobacteria, glycemic control, reduction of blood cholesterol, balancing the intestinal flora which aids in reducing constipation and/or diarrhea, improves intestinal permeability and stimulation of the immune system. Clinical indications for these products has been expanded, in order to maximize the individual's physiological functions to provide greater. So, with the high interest in the clinical and nutritional control of disease, many studies have been conducted demonstrating the effectiveness of using symbiotic in improving and/or preventing various and/or symptoms of gastrointestinal diseases. CONCLUSION: Symbiotic behave differently and positively in various pathological situations.


Gut Microbes ◽  
2014 ◽  
Vol 5 (5) ◽  
pp. 663-668 ◽  
Author(s):  
Eric W Rogier ◽  
Aubrey L Frantz ◽  
Maria EC Bruno ◽  
Leia Wedlund ◽  
Donald A Cohen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document